Neuronal Mechanisms of Obesity-Induced Hypertension
Neuronal Mechanisms of Obesity-Induced Hypertension
批准号:
10589241
负责人:
KAMAL RAHMOUNI
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-01-01 至 2026-12-31
关键词:
AblationAffectBlood PressureBrainCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemComplexCongestive Heart FailureConsciousDataDevelopmentEtiologyFRAP1 geneFunctional disorderGene DeletionGenesGenetic TranscriptionGenetically Engineered MouseGoalsHealthHealthcare SystemsHigh PrevalenceHypertensionHypothalamic structureKidneyKnowledgeLeptinLifeLigandsMeasuresMediatingMedicalMelanocortin 4 ReceptorMethodsMolecularMusMyocardial InfarctionNerveNeuronsObesityOrganOverweightPathway interactionsPhysiologicalPopulationPrevalenceProcessProtease InhibitorRegulationResearchRisk FactorsRoleSerineSignal TransductionStrokeSystemTechnologyTestingVeteransWeight GainWorkalpha-Melanocyte stimulating hormonecardiovascular risk factordiet-induced obesityglobal healthimprovedinnovationleptin receptormTOR proteinnovelpharmacologicpressurepreventpromoterprotective effectprotein complexside effectstandard of care
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The high prevalence of obesity among the veterans is a major challenge for the VA healthcare system. This is
because obesity is associated with increased sympathetic nerve traffic leading to hypertension, a major risk
factor for end-organ damage, stroke, myocardial infarction and congestive heart failure. However, the cellular
and molecular etiology of obesity-associated cardiovascular risks remain poorly understood. We and others
have previously demonstrated the importance of the brain mechanisms in the pathophysiology of obesity-
induced sympathetic activation and hypertension. Brain action of leptin and the melanocortinergic system have
emerged as major drivers of the increase in sympathetic nerve traffic and blood pressure in obesity. Studies
from our lab also revealed the importance of the mechanistic target of rapamycin complex 1 (mTORC1) in the
control of sympathetic nerve activity and blood pressure. Moreover, we provide compelling preliminary data
demonstrating that disruption of mTORC1 signaling in the leptin receptor (LepRb)-containing neurons interfere
selectively with the ability of leptin to increase renal sympathetic activity and blood pressure. Notably,
mTORC1 disruption in the LepRb neurons protect mice from the sympathetic overdrive and hypertension
evoked by diet-induced obesity without affecting weigh gain and adiposity. Moreover, we identified serine
peptidase inhibitor A3N (SerpinA3N) as a novel gene downstream to mTORC1 signaling. This led us to
hypothesize that mTORC1 signaling and SerpinA3N in the LepRb neurons mediate obesity-induced
sympathetic nerve activation and hypertension. We will test our hypothesis by examining the transcription
mechanisms that regulate SerpinA3N gene. In addition, we will investigate the role of SerpinA3N in the control
of sympathetic nerve traffic, arterial pressure and obesity-associated hypertension and sympathetic nerve
activation. We will also dissect the neurocircuit underlying the protection conferred by disruption of mTORC1
signaling in LepRb neurons on obesity-induced hypertension and sympathetic nerve activation. This research
will advance understanding of the mechanisms underlying the sympathetic overdrive and hypertension
associated with obesity that has become common in the VA population.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Involvement of a serotonin/GLP-1 circuit in adolescent isolation-induced diabetes.
血清素/GLP-1 回路参与青少年隔离诱发的糖尿病。
DOI:
10.1101/2023.06.12.544498
发表时间:
2023
期刊:
bioRxiv : the preprint server for biology
影响因子:
--
作者:
[Kolling,LouisJ, Khan,Kanza, Balasubramanian,Nagalakshmi, Guo,Deng-Fu, Rahmouni,Kamal, Marcinkiewcz,CatherineA]
通讯作者:
Marcinkiewcz,CatherineA
BLRD Research Career Scientist Award Application
-
批准号:10481383
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:KAMAL RAHMOUNI
-
依托单位:
Role of FGF21 Action in Hypothalamic Neurons in Obesity-Associated Hypertension
-
批准号:10583384
-
项目类别:
-
资助金额:$59.8万
-
财政年份:2022
-
负责人:KAMAL RAHMOUNI
-
依托单位:
BLRD Research Career Scientist Award Application
-
批准号:10593998
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:KAMAL RAHMOUNI
-
依托单位:
Neuronal Mechanisms of Obesity-Induced Hypertension
-
批准号:10265321
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:KAMAL RAHMOUNI
-
依托单位:
Neuronal Mechanisms of Obesity-Induced Hypertension
-
批准号:10428499
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:KAMAL RAHMOUNI
-
依托单位:
Role of Brain Bardet-Biedl Syndrome Genes in Metabolic and Cardiovas Regulation
-
批准号:8831714
-
项目类别:
-
资助金额:$47.93万
-
财政年份:2007
-
负责人:KAMAL RAHMOUNI
-
依托单位:
Role of Brain Bardet-Biedl Syndrome Genes in Metabolic and Cardiovas Regulation
-
批准号:9038409
-
项目类别:
-
资助金额:$48.66万
-
财政年份:2007
-
负责人:KAMAL RAHMOUNI
-
依托单位:
Neuronal Mechanisms of Obesity and Hypertension: Role of the BBSome
-
批准号:10445018
-
项目类别:
-
资助金额:$44.34万
-
财政年份:2007
-
负责人:KAMAL RAHMOUNI
-
依托单位:
Neuronal Mechanisms of Obesity and Hypertension: Role of the BBSome
-
批准号:10213810
-
项目类别:
-
资助金额:$44.34万
-
财政年份:2007
-
负责人:KAMAL RAHMOUNI
-
依托单位:
Role of Brain Bardet-Biedl Syndrome Genes in Metabolic and Cardiovas Regulation
-
批准号:8524231
-
项目类别:
-
资助金额:$46.28万
-
财政年份:2007
-
负责人:KAMAL RAHMOUNI
-
依托单位:
Role of Brain Bardet-Biedl Syndrome Genes in Metabolic and Cardiovas Regulation
-
批准号:8651938
-
项目类别:
-
资助金额:$47.68万
-
财政年份:2007
-
负责人:KAMAL RAHMOUNI
-
依托单位:
Neuronal Mechanisms of Obesity and Hypertension: Role of the BBSome
-
批准号:9977819
-
项目类别:
-
资助金额:$44.34万
-
财政年份:--
-
负责人:KAMAL RAHMOUNI
-
依托单位:
Neuronal Mechanisms of Obesity and Hypertension: Role of the BBSome
-
批准号:9750280
-
项目类别:
-
资助金额:$44.67万
-
财政年份:--
-
负责人:KAMAL RAHMOUNI
-
依托单位:
海外基金